(Q33677181)

28 July 2017

title

Cognitive-behavioral therapy to prevent relapse in pediatric responders to pharmacotherapy for major depressive disorder (English)

1 reference

major depressive disorder

28 July 2017

0 references

1 reference

cognitive behavioral therapy

inferred from title

1 reference

3

Taryn L Mayes

1 reference

28 July 2017

2

Graham J Emslie

1 reference

28 July 2017

1

Betsy D Kennard

1 reference

28 July 2017

5

Paul A Nakonezny

1 reference

28 July 2017

author name string

Jeanne Nightingale-Teresi

4

1 reference

28 July 2017

Jennifer L Hughes

6

1 reference

28 July 2017

Jessica M Jones

7

1 reference

28 July 2017

Rongrong Tao

8

1 reference

28 July 2017

Sunita M Stewart

9

1 reference

28 July 2017

Robin B Jarrett

10

1 reference

28 July 2017

publication date

1 December 2008

1 reference

Journal of the American Academy of Child and Adolescent Psychiatry

28 July 2017

published in

1 reference

28 July 2017

volume

47

1 reference

28 July 2017

issue

12

1 reference

28 July 2017

page(s)

1395-1404

1 reference

Developing Cognitive Behavioral Therapy to Prevent Depressive Relapse in Youth

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826176

Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826176

Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826176

Reducing relapse and recurrence in unipolar depression: a comparative meta-analysis of cognitive-behavioral therapy's effects

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826176

Texas Children's Medication Algorithm Project: update from Texas Consensus Conference Panel on Medication Treatment of Childhood Major Depressive Disorder

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826176

Relapse and recurrence in pediatric depression

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826176

Effects of psychotherapy for depression in children and adolescents: a meta-analysis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826176

Review of the efficacy and safety of antidepressants in youth depression

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826176

Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826176

Development and natural history of mood disorders

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826176

Preventing recurrent depression using cognitive therapy with and without a continuation phase: a randomized clinical trial

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826176

Assessment of patient satisfaction: development and refinement of a service evaluation questionnaire

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826176

Assessment of client/patient satisfaction: development of a general scale

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826176

Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826176

A children's global assessment scale (CGAS)

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826176

The family history approach to diagnosis. How useful is it?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826176

Continuation treatment with antidepressants in child and adolescent major depression

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826176

Remission and residual symptoms after short-term treatment in the Treatment of Adolescents with Depression Study (TADS).

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826176

Fluoxetine treatment for prevention of relapse of depression in children and adolescents: a double-blind, placebo-controlled study

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826176

Long-term management of chronic depression.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826176

The treatment of chronic depression, part 1: study design and rationale for evaluating the comparative efficacy of sertraline and imipramine as acute, crossover, continuation, and maintenance phase therapies.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826176

Six-year outcome for cognitive behavioral treatment of residual symptoms in major depression.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2826176

Cognitive-behavioral treatment of adolescent depression: efficacy of acute group treatment and booster sessions

30 October 2018

1 reference

12 December 2020

Pilot study of continuation cognitive-behavioral therapy for major depression in adolescent psychiatric patients

1 reference

12 December 2020

Four-year outcome for cognitive behavioral treatment of residual symptoms in major depression

1 reference

12 December 2020

Is there a role for continuation phase cognitive therapy for depressed outpatients?

1 reference

12 December 2020

Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy

1 reference

12 December 2020

Preventing Relapse/Recurrence in Recurrent Depression With Cognitive Therapy: A Randomized Controlled Trial

1 reference

12 December 2020

Cognitive behavioral treatment of residual symptoms in primary major depressive disorder

1 reference

12 December 2020

Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report

1 reference

12 December 2020

Prevention of relapse in residual depression by cognitive therapy: a controlled trial

1 reference

12 December 2020

10.1097/CHI.0B013E31818914A1

Identifiers

DOI

1 reference

28 July 2017

1 reference

28 July 2017

1 reference